Distribution of anthropometric, clinical, and metabolic profiles of women with polycystic ovary syndrome across the four regions of India

Context: Polycystic ovary syndrome (PCOS), one of the most common endocrine disorders encountered in women of reproductive age, is associated with an increased prevalence of metabolic syndrome (MetS). Development of PCOS and its phenotypic expressions is influenced by genetic, ethnic and environmental factors. Due to the vast cultural diversity in our country, differences in the prevalence of MetS may exist across different regions. Aims and Objectives: To study the distribution of anthropometric, clinical, and metabolic profiles of women with PCOS across the four regions of India. Materials and Methods: A multicentric prospective study using data collected from four tertiary Assisted Reproductive Centres across four different regions of India was carried out between January 2017 and December 2017. A total of 651 women were diagnosed with PCOS, with 178 belonging to North, 209 to East, 115 to West and 149 to South India. A comparison of the metabolic and anthropometric profiles of women with PCOS was made across the four different ethnic regions of India. Statistical Analysis: Quantitative variables were compared using the Mann–Whitney test and qualitative variables using the Chi-square test.P < 0.05 was considered statistically significant. Results: North Indian women had the highest mean body mass index (BMI) – 27.53 ± 4.55 kg/m2 and a higher waist circumference (89.93 ± 14.53 cm) compared to women from South and West India (P = 0.0001). The prevalence of MetS (41.98%) and impaired glucose tolerance (IGT) (37.04%) was also highest in North India followed by East India. PCOS women from East India were lean but had the highest waist-to-hip ratio (WHR) 0.9 ± 0.05 (P = 0.0001) and dyslipidemia. Using multivariate logistical regression analysis, age >25 years, BMI >25 kg/m2, and WHR >0.8 had a strong association with MetS. Conclusion: Prevalence of MetS is high among Indian PCOS women, with women from the North and East India having the worst metabolic profiles. IGT is the main driver for MetS.

[1]  T. Piltonen,et al.  Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross‐sectional study , 2017, American journal of obstetrics and gynecology.

[2]  A. Ruokonen,et al.  Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life. , 2017, Fertility and sterility.

[3]  A. Majumdar,et al.  Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women , 2015, Journal of human reproductive sciences.

[4]  R. Vaidya,et al.  A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India , 2014, Indian journal of endocrinology and metabolism.

[5]  A. Dokras Cardiovascular disease risk in women with PCOS , 2013, Steroids.

[6]  S. Kar Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A prospective study of PCOS women , 2013, Journal of human reproductive sciences.

[7]  Z. Kabir,et al.  Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India , 2012, Journal of cardiovascular disease research.

[8]  L. Moran,et al.  Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. , 2010, Human reproduction update.

[9]  William A. Davis,et al.  Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. , 2007, Fertility and sterility.

[10]  R. Kimmig,et al.  Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[11]  J. Adams,et al.  Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. , 2006, The Journal of clinical endocrinology and metabolism.

[12]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[13]  A. Dokras,et al.  Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome , 2005, Obstetrics and gynecology.

[14]  P. McKeigue,et al.  Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study , 2005, Diabetologia.

[15]  S. Joshi Metabolic syndrome--emerging clusters of the Indian phenotype. , 2003, The Journal of the Association of Physicians of India.

[16]  R. Lobo,et al.  Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. , 1999, The Journal of clinical endocrinology and metabolism.

[17]  M. Marmot,et al.  Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans , 1992, Diabetologia.

[18]  M. Marmot,et al.  Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London. , 1988, British heart journal.

[19]  H. Teede,et al.  Polycystic ovary syndrome , 2016, Nature Reviews Disease Primers.

[20]  Sujoy Ghosh,et al.  Metabolic syndrome in South Asians , 2012, Indian journal of endocrinology and metabolism.

[21]  R. Seneviratne,et al.  Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. , 2011, Human reproduction.

[22]  V. Mohan,et al.  The metabolic syndrome in South Asians. , 2007 .

[23]  N. Napoli,et al.  Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. , 2006, European journal of endocrinology.

[24]  D. Ehrmann,et al.  Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[25]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.